Intranasal desmopressin (Octim™): A safe and efficacious treatment option for children with bleeding disorders

Haemophilia

Volumn 13, Issue 5, 2007, Pages 548-551

  Khair, K ^a   Baker, K ^a   Mathias, M ^a   Burgess, C ^a   Liesner, R ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Bleeding; Children; DDAVP; Desmopressin; Intranasal

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; OCTIM; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; BLEEDING DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEMOPHILIA A; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; CHILD; COHORT STUDIES; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOPHILIA A; HEMORRHAGE; HEMOSTATICS; HUMANS; MALE; TREATMENT OUTCOME;

EID: 34548317169     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01519.x     Document Type: Article

References (8)

1. Lethagan S. Desmopressin in mild haemophilia A: Indications, limitations, efficacy and safety. Semin Thromb Hemost 2003; 1: 101-6.
2. Revel-Vilk S, Schmugge M, Carcao MD, Blanchette P, Rand ML, Blanchette VS. Desmopressin (DDAVP) responsiveness in children with von willebrand disease. J Pediatr Hematol Oncol 2003; 11: 874-9.
3. Rodeghiero F, Castaman G, Mannucci PM. Prospective multicentre study on subcutaneous concentrated desmopressin for home treatment of patients with von-Willebrand disease and mild or moderate haemophilia A. Thromb Haemost 1996; 5: 692-6.
4. Leissinger C, Becton D, Cornell C Jr, Cox Gill J. High dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A. Haemophilia 2001; 3: 258-66.
5. Kadir R, Lee CA, Sabin CA, Pollard D, Economides DL. DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomised placebo-controlled crossover study. Haemophilia 2002; 6: 787-93.
6. UKHCDO. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003; 1: 1-23.
7. Simons FE, Gu X, Johnston LM, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphlaxis? Pediatrics 2000; 5: 1040-4.
8. Francis JD, Laery T, Niblett DJ. Convulsions and respiratory arrest in association with desmopressin administration for the treatment of a bleeding tonsil in a child with borderline haemophilia. Acta Anesthesiol Scand 1999; 8: 870-3.